Tuesday, October 15, 2013

New form of ocular therapy could improve the quality of life for patients with eye disease

Two professors are working together to create a drug delivery system for patients with chronic eye disease. This new system won't require as much maintenance and will also help decrease the number of monthly visits to the doctor's office. This tiny film will help create a more target based delivery method, which will ultimately help minimize the risk of infection, as well the burden of painful injections.

Robert Bhisitkul, MD, PhD, a professor of clinical opthamology at UC San Francisco, is all too familiar with this challenge and is working with Tejal Desai, PhD, professor of bioengineering and therapeutic sciences, on a solution to help improve the lives of patients.Desai works on the design, fabrication and use of advanced micro/nano biosystems, and has been developing a tiny, flexible, implantable film that is able to deliver conventional medicines and also complex antibody-based drugs used in retinal disease therapies.

This new target based delivery approach could help reduce side effects, and increase patient compliance. How can collaborations like this help revolutionize target based delivery devices in the future?

Want to learn more about the latest in drug delivery? IIR's 18th Annual Drug Delivery Partnerships will help you form a drug delivery strategy that keeps you ahead of the market, register today! To learn more, download our agenda. We hope to see you January 27-29 in Boca Raton!

No comments:

Post a Comment